{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:12:06Z","timestamp":1788844326607,"version":"build-2803163510"},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"am","delay-in-days":381,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lpm.2021.104074","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T23:47:09Z","timestamp":1632354429000},"page":"104074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Genetics of lipodystrophy syndromes"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7171-0577","authenticated-orcid":false,"given":"Isabelle","family":"J\u00e9ru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2021.104074_bib0001","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1210\/jc.2016-2466","article-title":"The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline","volume":"101","author":"Brown","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104074_bib0002","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2021.104074_bib0003","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86870","article-title":"Whole-exome sequencing identifies ADRA2A mutation in atypical familial partial lipodystrophy","volume":"1","author":"Garg","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.lpm.2021.104074_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0005","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.lpm.2021.104074_bib0006","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/ajmg.a.34249","article-title":"Nestor-Guillermo progeria syndrome: a novel premature aging condition with early onset and chronic development caused by BANF1 mutations","volume":"155A","author":"Cabanillas","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.lpm.2021.104074_bib0007","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/0092-8674(95)90105-1","article-title":"The Bloom's syndrome gene product is homologous to RecQ helicases","volume":"83","author":"Ellis","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.lpm.2021.104074_bib0008","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magre","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0009","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-7-3","article-title":"Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia","volume":"7","author":"Cao","year":"2008","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.lpm.2021.104074_bib0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104074_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131797","article-title":"A Frame-Shift Mutation in CAV1 Is Associated with a Severe Neonatal Progeroid and Lipodystrophy Syndrome","volume":"10","author":"Schrauwen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2021.104074_bib0012","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1172\/JCI38660","article-title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy","volume":"119","author":"Hayashi","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2021.104074_bib0013","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/humu.21154","article-title":"Mutation update for the CSB\/ERCC6 and CSA\/ERCC8 genes involved in Cockayne syndrome","volume":"31","author":"Laugel","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.lpm.2021.104074_bib0015","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1002\/ajmg.a.33690","article-title":"Marfan syndrome with neonatal progeroid syndrome-like lipodystrophy associated with a novel frameshift mutation at the 3\u2032 terminus of the FBN1-gene","volume":"152A","author":"Graul-Neumann","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.lpm.2021.104074_bib0016","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ajhg.2014.12.011","article-title":"Keppen-Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6","volume":"96","author":"Masotti","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0017","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1315496","article-title":"Null mutation in hormone-sensitive lipase gene and risk of type 2 diabetes","volume":"370","author":"Albert","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2021.104074_bib0018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature01629","article-title":"Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome","volume":"423","author":"Eriksson","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2021.104074_bib0019","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin a truncation in Hutchinson-Gilford progeria","volume":"300","author":"De Sandre-Giovannoli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.lpm.2021.104074_bib0020","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/341908","article-title":"Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A\/C","volume":"71","author":"Novelli","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0021","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/hmg\/ddv229","article-title":"Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy","volume":"24","author":"Sawyer","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0022","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1038\/s41467-020-18146-9","article-title":"Loss of MTX2 causes mandibuloacral dysplasia and links mitochondrial dysfunction to altered nuclear morphology","volume":"11","author":"Elouej","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.lpm.2021.104074_bib0023","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a001156","article-title":"Optic atrophy, cataracts, lipodystrophy\/lipoatrophy, and peripheral neuropathy caused by a de novo OPA3 mutation","volume":"3","author":"Bourne","year":"2017","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"10.1016\/j.lpm.2021.104074_bib0024","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.1073\/pnas.1612594113","article-title":"Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease","volume":"113","author":"Zhou","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2021.104074_bib0025","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ajhg.2013.11.018","article-title":"Mutations in PCYT1A, encoding a key regulator of phosphatidylcholine metabolism, cause spondylometaphyseal dysplasia with cone-rod dystrophy","volume":"94","author":"Hoover-Fong","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0026","doi-asserted-by":"crossref","first-page":"8901","DOI":"10.1073\/pnas.1408523111","article-title":"Mutations disrupting the Kennedy phosphatidylcholine pathway in humans with congenital lipodystrophy and fatty liver disease","volume":"111","author":"Payne","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2021.104074_bib0027","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajhg.2013.11.022","article-title":"Mutations in PCYT1A cause spondylometaphyseal dysplasia with cone-rod dystrophy","volume":"94","author":"Yamamoto","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0028","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ajhg.2013.05.019","article-title":"PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy","volume":"93","author":"Thauvin-Robinet","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0029","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ajhg.2013.06.005","article-title":"Mutations in PIK3R1 cause SHORT syndrome","volume":"93","author":"Dyment","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0030","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1056\/NEJMoa1007487","article-title":"Perilipin deficiency and autosomal dominant partial lipodystrophy","volume":"364","author":"Gandotra","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2021.104074_bib0031","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1210\/jc.2019-00849","article-title":"Diagnostic Challenge in PLIN1-Associated Familial Partial Lipodystrophy","volume":"104","author":"Jeru","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104074_bib0032","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ng.2670","article-title":"An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy","volume":"45","author":"Weedon","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0033","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/jmedgenet-2018-105528","article-title":"Specific combinations of biallelic POLR3A variants cause Wiedemann-Rautenstrauch syndrome","volume":"55","author":"Paolacci","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0034","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1172\/JCI81260","article-title":"Additive loss-of-function proteasome subunit mutations in CANDLE\/PRAAS patients promote type I IFN production","volume":"125","author":"Brehm","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2021.104074_bib0035","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2021.104074_bib0036","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ajhg.2010.10.031","article-title":"PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome","volume":"87","author":"Agarwal","year":"2010","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0037","doi-asserted-by":"crossref","first-page":"1939-43 e8","DOI":"10.1016\/j.jaci.2018.12.1012","article-title":"Novel proteasome assembly chaperone mutations in PSMG2\/PAC2 cause the autoinflammatory interferonopathy CANDLE\/PRAAS4","volume":"143","author":"de Jesus","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lpm.2021.104074_bib0038","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cge.13746","article-title":"Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants","volume":"98","author":"Ranza","year":"2020","journal-title":"Clin Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0039","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ajhg.2017.09.017","article-title":"De Novo Mutations in SLC25A24 Cause a Disorder Characterized by Early Aging, Bone Dysplasia, Characteristic Face, and Early Demise","volume":"101","author":"Writzl","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0040","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1515\/jpem-2013-0062","article-title":"Pigmentary hypertrichosis and non-autoimmune insulin-dependent diabetes mellitus (PHID) syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome","volume":"26","author":"Senniappan","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104074_bib0041","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng.3103","article-title":"Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features","volume":"46","author":"Lessel","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0042","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1750-1172-8-106","article-title":"Partial lipodystrophy with severe insulin resistance and adult progeria Werner syndrome","volume":"8","author":"Donadille","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.lpm.2021.104074_bib0043","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/hmg\/ddg213","article-title":"Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia","volume":"12","author":"Agarwal","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0044","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(46)90528-4","article-title":"Lipodystrophy and hepatomegaly, with diabetes, lipaemia, and other metabolic disturbances; a case throwing new light on the action of insulin","volume":"1","author":"Lawrence","year":"1946","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2021.104074_bib0045","doi-asserted-by":"crossref","first-page":"D944","DOI":"10.2741\/Leung","article-title":"The structure and functions of human lysophosphatidic acid acyltransferases","volume":"6","author":"Leung","year":"2001","journal-title":"Front Biosci"},{"key":"10.1016\/j.lpm.2021.104074_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10071435","article-title":"Celia's Encephalopathy (BSCL2-Gene-Related): Current Understanding","volume":"10","author":"Sanchez-Iglesias","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.lpm.2021.104074_bib0047","doi-asserted-by":"crossref","first-page":"20890","DOI":"10.1073\/pnas.0704154104","article-title":"The lipodystrophy protein seipin is found at endoplasmic reticulum lipid droplet junctions and is important for droplet morphology","volume":"104","author":"Szymanski","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2021.104074_bib0048","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nrendo.2015.123","article-title":"Congenital generalized lipodystrophies\u2013new insights into metabolic dysfunction","volume":"11","author":"Patni","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.lpm.2021.104074_bib0049","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/qjmed\/90.1.27","article-title":"Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy","volume":"90","author":"Jackson","year":"1997","journal-title":"QJM"},{"key":"10.1016\/j.lpm.2021.104074_bib0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0051","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/jmedgenet-2016-104437","article-title":"LMNA-associated partial lipodystrophy: anticipation of metabolic complications","volume":"54","author":"Jeru","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0052","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad4991","article-title":"Laminopathies disrupt epigenomic developmental programs and cell fate","volume":"8","author":"Perovanovic","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lpm.2021.104074_bib0053","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1021\/bi020704g","article-title":"The carboxyl-terminal region common to lamins A and C contains a DNA binding domain","volume":"42","author":"Stierle","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.lpm.2021.104074_bib0054","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104074_bib0055","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.lpm.2021.104074_bib0056","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1038\/ng.3700","article-title":"Prospective functional classification of all possible missense variants in PPARG","volume":"48","author":"Majithia","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/j.lpm.2021.104074_bib0057","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1097-2765(00)80211-7","article-title":"PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro","volume":"4","author":"Rosen","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.lpm.2021.104074_bib0058","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jacl.2018.07.009","article-title":"MFN2-associated lipomatosis: Clinical spectrum and impact on adipose tissue","volume":"12","author":"Capel","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.lpm.2021.104074_bib0059","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23813","article-title":"Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression","volume":"6","author":"Rocha","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.lpm.2021.104074_bib0060","doi-asserted-by":"crossref","first-page":"11249","DOI":"10.1073\/pnas.1606786113","article-title":"Critical reappraisal confirms that Mitofusin 2 is an endoplasmic reticulum-mitochondria tether","volume":"113","author":"Naon","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2021.104074_bib0061","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1242\/jcs.114.5.867","article-title":"Control of mitochondrial morphology by a human mitofusin","volume":"114","author":"Santel","year":"2001","journal-title":"J Cell Sci"},{"key":"10.1016\/j.lpm.2021.104074_bib0062","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/mus.24157","article-title":"Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin","volume":"49","author":"Carboni","year":"2014","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2021.104074_bib0063","first-page":"1649","article-title":"A novel LIPE nonsense mutation found using exome sequencing in siblings with late-onset familial partial lipodystrophy","volume":"30","author":"Farhan","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.lpm.2021.104074_bib0064","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1530\/EJE-20-1013","article-title":"LIPE-related lipodystrophic syndrome: clinical features and disease modeling using adipose stem cells","volume":"184","author":"Sollier","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.lpm.2021.104074_bib0065","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MOL.0b013e32811e16fb","article-title":"The role of neutral lipases in human adipose tissue lipolysis","volume":"18","author":"Arner","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.lpm.2021.104074_bib0066","doi-asserted-by":"crossref","first-page":"14914","DOI":"10.1073\/pnas.1106015108","article-title":"Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome","volume":"108","author":"Arima","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.lpm.2021.104074_bib0067","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1172\/JCI58414","article-title":"A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans","volume":"121","author":"Kitamura","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2021.104074_bib0068","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.33368","article-title":"Mutations in proteasome subunit beta type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity","volume":"64","author":"Liu","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2021.104074_bib0069","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","article-title":"The mutational constraint spectrum quantified from variation in 141,456 humans","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2021.104074_bib0070","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.lpm.2021.104074_bib0071","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00125-012-2794-8","article-title":"Reassessment of the putative role of BLK-p.A71T loss-of-function mutation in MODY and type 2 diabetes","volume":"56","author":"Bonnefond","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.lpm.2021.104074_bib0072","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/humu.23289","article-title":"Analysis of large-scale sequencing cohorts does not support the role of variants in UCP2 as a cause of hyperinsulinaemic hypoglycaemia","volume":"38","author":"Laver","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1016\/j.lpm.2021.104074_bib0073","doi-asserted-by":"crossref","first-page":"65ra4","DOI":"10.1126\/scitranslmed.3001756","article-title":"Carrier testing for severe childhood recessive diseases by next-generation sequencing","volume":"3","author":"Bell","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.lpm.2021.104074_bib0074","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.lpm.2021.104074_bib0075","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1210\/jc.2017-02662","article-title":"PLIN1 Haploinsufficiency Is Not Associated With Lipodystrophy","volume":"103","author":"Laver","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.lpm.2021.104074_bib0076","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2147\/DMSO.S130810","article-title":"Estimating the prevalence of generalized and partial lipodystrophy: findings and challenges","volume":"10","author":"Chiquette","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.lpm.2021.104074_bib0077","doi-asserted-by":"crossref","first-page":"22","DOI":"10.12688\/wellcomeopenres.15090.2","article-title":"Genomic variant sharing: a position statement","volume":"4","author":"Wright","year":"2019","journal-title":"Wellcome Open Res"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498221000130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:08:22Z","timestamp":1760105302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498221000130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0755498221000130"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104074","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of lipodystrophy syndromes","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2021.104074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104074"}}